Bulevirtide vs Desmopressin
Overview
Bulevirtide is primarily a antiviral peptide, while Desmopressin is used for hormonal.
This page compares Bulevirtide and Desmopressin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Bulevirtide | Desmopressin | |
|---|---|---|
| Category | Antiviral | Hormonal |
| Regulatory status (US) | FDA approved | FDA approved |
| Typical dosage | — | 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) |
| Frequency | — | Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia) |
| Reported benefits | — | central diabetes insipidus management, primary nocturnal enuresis in children, nocturia due to nocturnal polyuria, perioperative hemostasis in mild hemophilia A, hemostasis in Type I von Willebrand disease, management of polyuria following head trauma or pituitary surgery |
| Reported side effects | — | hyponatremia (boxed warning), headache, facial flushing, nausea, abdominal cramps, fluid retention, hypotension, reflex tachycardia, hypertension, tachyphylaxis with repeated dosing, rare anaphylaxis |
Key differences
Primary use. Bulevirtide is categorised under Antiviral, while Desmopressin falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Bulevirtide: FDA-approved. Desmopressin: FDA-approved.
Dosing. Typical dosing for Bulevirtide is not catalogued. Desmopressin is typically dosed at 0.1–0.8 mg/day oral (central DI); 0.3 mcg/kg IV (hemostasis, max 20 mcg); 0.2–0.6 mg at bedtime (nocturnal enuresis); 27.7–55.3 mcg sublingual (nocturia) (Once to twice daily (oral); single IV infusion or every 8–12 hours (hemostasis); once nightly (nocturia)).
Can you stack them?
Some protocols combine peptides, but stacking Bulevirtide and Desmopressin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Bulevirtide and Desmopressin?
- Bulevirtide is primarily a antiviral peptide, while Desmopressin is used for hormonal. Bulevirtide is FDA-approved for one or more indications, whereas Desmopressin is FDA-approved for one or more indications.
- What is Bulevirtide used for?
- First/only FDA-approved treatment for chronic hepatitis delta virus (HDV). FDA accelerated approval May 22, 2026. Brand: Hepcludex (Gilead).
- What is Desmopressin used for?
- Synthetic ADH analog (DDAVP) FDA-approved for diabetes insipidus, nocturnal enuresis, and bleeding disorders.
- Can you take Bulevirtide and Desmopressin together?
- Some users combine peptides within a single protocol, but stacking Bulevirtide and Desmopressin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Bulevirtide or Desmopressin FDA-approved?
- Bulevirtide is FDA-approved for one or more indications. Desmopressin is FDA-approved for one or more indications.
Read the full articles
- Bulevirtide — full monograph: mechanism, research, dosing & references
- Desmopressin — full monograph: mechanism, research, dosing & references